Literature DB >> 17540369

Increased chondroitin sulfate proteoglycan expression in denervated brainstem targets following spinal cord injury creates a barrier to axonal regeneration overcome by chondroitinase ABC and neurotrophin-3.

James M Massey1, Jeremy Amps, Mariano S Viapiano, Russell T Matthews, Michelle R Wagoner, Christopher M Whitaker, Warren Alilain, Alicia L Yonkof, Abdelnaby Khalyfa, Nigel G F Cooper, Jerry Silver, Stephen M Onifer.   

Abstract

Increased chondroitin sulfate proteoglycan (CSPG) expression in the vicinity of a spinal cord injury (SCI) is a primary participant in axonal regeneration failure. However, the presence of similar increases of CSPG expression in denervated synaptic targets well away from the primary lesion and the subsequent impact on regenerating axons attempting to approach deafferented neurons have not been studied. Constitutively expressed CSPGs within the extracellular matrix and perineuronal nets of the adult rat dorsal column nuclei (DCN) were characterized using real-time PCR, Western blot analysis and immunohistochemistry. We show for the first time that by 2 days and through 3 weeks following SCI, the levels of NG2, neurocan and brevican associated with reactive glia throughout the DCN were dramatically increased throughout the DCN despite being well beyond areas of trauma-induced blood brain barrier breakdown. Importantly, regenerating axons from adult sensory neurons microtransplanted 2 weeks following SCI between the injury site and the DCN were able to regenerate rapidly within white matter (as shown previously by Davies et al. [Davies, S.J., Goucher, D.R., Doller, C., Silver, J., 1999. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J. Neurosci. 19, 5810-5822]) but were unable to enter the denervated DCN. Application of chondroitinase ABC or neurotrophin-3-expressing lentivirus in the DCN partially overcame this inhibition. When the treatments were combined, entrance by regenerating axons into the DCN was significantly augmented. These results demonstrate both an additional challenge and potential treatment strategy for successful functional pathway reconstruction after SCI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540369      PMCID: PMC2270474          DOI: 10.1016/j.expneurol.2007.03.029

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  109 in total

Review 1.  Trk receptors: roles in neuronal signal transduction.

Authors:  Eric J Huang; Louis F Reichardt
Journal:  Annu Rev Biochem       Date:  2003-03-27       Impact factor: 23.643

Review 2.  Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS?

Authors:  K E Rhodes; J W Fawcett
Journal:  J Anat       Date:  2004-01       Impact factor: 2.610

3.  Primary afferent terminal sprouting after a cervical dorsal rootlet section in the macaque monkey.

Authors:  Corinna Darian-Smith
Journal:  J Comp Neurol       Date:  2004-03-01       Impact factor: 3.215

Review 4.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

5.  Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.

Authors:  Jeannette E Davies; Xiufeng Tang; Jeremy W Denning; Simon J Archibald; Stephen J A Davies
Journal:  Eur J Neurosci       Date:  2004-03       Impact factor: 3.386

6.  PKC mediates inhibitory effects of myelin and chondroitin sulfate proteoglycans on axonal regeneration.

Authors:  Rajeev Sivasankaran; Jiong Pei; Kevin C Wang; Yi Ping Zhang; Christopher B Shields; Xiao-Ming Xu; Zhigang He
Journal:  Nat Neurosci       Date:  2004-02-08       Impact factor: 24.884

7.  A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.

Authors:  Mariano S Viapiano; Russell T Matthews; Susan Hockfield
Journal:  J Biol Chem       Date:  2003-06-10       Impact factor: 5.157

8.  Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain.

Authors:  Thomas C Brionne; Ina Tesseur; Eliezer Masliah; Tony Wyss-Coray
Journal:  Neuron       Date:  2003-12-18       Impact factor: 17.173

9.  Intact aggrecan and chondroitin sulfate-depleted aggrecan core glycoprotein inhibit axon growth in the adult rat spinal cord.

Authors:  Michele L Lemons; John D Sandy; Douglas K Anderson; Dena R Howland
Journal:  Exp Neurol       Date:  2003-12       Impact factor: 5.330

10.  A novel DNA enzyme reduces glycosaminoglycan chains in the glial scar and allows microtransplanted dorsal root ganglia axons to regenerate beyond lesions in the spinal cord.

Authors:  Barbara Grimpe; Jerry Silver
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

View more
  70 in total

1.  Role of chondroitin sulfate proteoglycans in axonal conduction in Mammalian spinal cord.

Authors:  Arsen S Hunanyan; Guillermo García-Alías; Valentina Alessi; Joel M Levine; James W Fawcett; Lorne M Mendell; Victor L Arvanian
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Chondroitinase ABC promotes selective reactivation of somatosensory cortex in squirrel monkeys after a cervical dorsal column lesion.

Authors:  Charnese Bowes; James M Massey; Mark Burish; Christina M Cerkevich; Jon H Kaas
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Alterations in chondroitin sulfate proteoglycan expression occur both at and far from the site of spinal contusion injury.

Authors:  Ellen M Andrews; Rebekah J Richards; Feng Q Yin; Mariano S Viapiano; Lyn B Jakeman
Journal:  Exp Neurol       Date:  2011-09-17       Impact factor: 5.330

4.  Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways.

Authors:  Xingxing Wang; Omar Hasan; Alexander Arzeno; Larry I Benowitz; William B J Cafferty; Stephen M Strittmatter
Journal:  Exp Neurol       Date:  2012-06-21       Impact factor: 5.330

5.  Loss and spontaneous recovery of forelimb evoked potentials in both the adult rat cuneate nucleus and somatosensory cortex following contusive cervical spinal cord injury.

Authors:  Stephen M Onifer; Christine D Nunn; Julie A Decker; Beth N Payne; Michelle R Wagoner; Aaron H Puckett; James M Massey; James Armstrong; Ezidin G Kaddumi; Kimberly G Fentress; Michael J Wells; Robert M West; Charles C Calloway; Jeffrey T Schnell; Christopher M Whitaker; Darlene A Burke; Charles H Hubscher
Journal:  Exp Neurol       Date:  2007-06-30       Impact factor: 5.330

6.  Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.

Authors:  Jung-Yu C Hsu; Lilly Y W Bourguignon; Christen M Adams; Karine Peyrollier; Haoqian Zhang; Thomas Fandel; Christine L Cun; Zena Werb; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2008-12-10       Impact factor: 6.167

Review 7.  Translational spinal cord injury research: preclinical guidelines and challenges.

Authors:  Paul J Reier; Michael A Lane; Edward D Hall; Y D Teng; Dena R Howland
Journal:  Handb Clin Neurol       Date:  2012

8.  Rolipram attenuates acute oligodendrocyte death in the adult rat ventrolateral funiculus following contusive cervical spinal cord injury.

Authors:  Christopher M Whitaker; Eric Beaumont; Michael J Wells; David S K Magnuson; Michal Hetman; Stephen M Onifer
Journal:  Neurosci Lett       Date:  2008-04-08       Impact factor: 3.046

9.  Comparison of sensory neuron growth cone and filopodial responses to structurally diverse aggrecan variants, in vitro.

Authors:  Justin A Beller; Brandon Kulengowski; Edward M Kobraei; Gabrielle Curinga; Christopher M Calulot; Azita Bahrami; Thomas M Hering; Diane M Snow
Journal:  Exp Neurol       Date:  2013-03-01       Impact factor: 5.330

Review 10.  A systematic review of directly applied biologic therapies for acute spinal cord injury.

Authors:  Brian K Kwon; Elena B Okon; Ward Plunet; Darryl Baptiste; Karim Fouad; Jessica Hillyer; Lynne C Weaver; Michael G Fehlings; Wolfram Tetzlaff
Journal:  J Neurotrauma       Date:  2010-06-16       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.